pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Merck & Co., Inc. ($MRK) · news · pharmadog
← back to Merck & Co., Inc.
News mentioning $MRK
11
stories
18d
DPHARM: How to address the clinical trial enrollment crisis?
fiercebiotech
19d
Novo looks to Anthropic’s AI models to ‘supercharge’ drug development
biopharma dive
25d
Chutes & Ladders—Longtime Takeda R&D chief to depart next June
fiercebiotech
Aug 26, 26
Spyre tumbles as immune drug misses mark in rheumatoid arthritis
biopharma dive
Aug 26, 26
Hansoh heralds China’s move from ‘follower’ to ‘frontrunner’ in biopharma race
fiercebiotech
Aug 26, 26
Spyre’s rheumatoid arthritis plan toppled by subpar TL1A data
fiercebiotech
Aug 5, 26
Attovia adds to biotech IPO momentum with $289M offering
biopharma dive
Aug 4, 26
J&J pharma leader to retire; Krystal slumps on gene therapy miss
biopharma dive
Jul 17, 26
FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol in Adults with High Cholesterol
fda press
May 18, 26
Merck ADC, licensed from China, hits mark in first big global trial
biopharma dive
May 8, 26
Capivasertib/Fulvestrant Yields Numerical OS Advantage in PIK3CA/AKT1/PTEN–Altered Breast Cancer
onclive
